CD8A and myeloid sarcoma: Our findings correspond to the findings from another research group investigating CD8+ T lymphocytes only, who did not observe a significant difference in the number of somatic variants in 2,524 immunity and cancer-related genes between 21 recently diagnosed individuals with MS and 21 sex- and age-matched controls (18).